echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Consistency evaluation TOP10 enterprise analysis: Qilu lead Zhengdaqing, Huahai followed closely behind

    Consistency evaluation TOP10 enterprise analysis: Qilu lead Zhengdaqing, Huahai followed closely behind

    • Last Update: 2020-06-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Consistency evaluation, since the policy landed so far, has been very fruitful! Most of the pillar varieties of enterprises have been through evaluation or into the declaration stage, the quality of domestic imitation varieties is climbingAlthough, not long ago, a domestic pharmaceutical tycoon announced that it will cut off most of the generic drug business, the industry also put forward some discussions on imitation and innovation, but it has to be admitted that the domestic has not really crossed the threshold of new drugs, the status of generic drugs in the domestic will remain short-term unshakable, and then the consistency evaluation of the work will continueThis manuscript is the statistics of the current domestic consistency evaluation through the number of varieties of TOP10 enterprises, and observe the imitation of these enterprises business, but also to push back the status of generic drugs in China1Consistency evaluation TOP10 enterprisesthrough the drug intelligence data query, the current consistency evaluation of the top 10 varieties of work through the number of enterprises in turn qilu pharmaceutical, Zhengda Tianqing, Zhejiang Huahai, Sichuan Kolun, Ishiguro, Jiangsu Howson, Jiangsu Hengrui, Shenzhen Xinlitai, Chongqing pharmaceutical Friends, Zhejiang Jingxin; among them, Qilu Pharmaceutical declared 30 varieties, through 13 varieties, are in the lead; Zhengda Day clear declaration of 20 varieties, through 11, the pass rate is relatively high; Zhejiang Huahai declared 18 varieties, through 11, the pass rate is relatively highSee below for detailsimage sits from pharmacological data
    2Qilu leads the way, Tianqing, Huahai followed closelyas mentioned above, Qilu Pharmaceuticals is in the first place, both in the number of varieties declared or through the number of varieties; Tebifen tablets, succinic solin tablets, onitrogen flat tablets, onitrogen flats, hydrochloric acid left sitiliquin tablets, hydrochloric acid anitanis, lipeone tablets, hydrochloric acid qumeritin tablets, tequio capsules, Adfoveesttablets, warfarin sodium tablets, have passed the consistency evaluationPS: According to the company's official website, Qilu Pharmaceutical's Laado amine capsule, lipeone dachleula, hydrochloric acid qumetatin slow release tablets have passed the consistency evaluation, so far, 12 varieties for the first domestic, 6 varieties for exclusiveand obviously contains large varietiesis sunny, the first species through the consistency evaluation of the varieties is fumaric acid tinofovvir dipolyphan tablets (2017/12), the first declared varieties are Entikavir dispersion tablets (the company's second adopted varieties), are antiviral varieties;, metformine hydrochloride, metasulphate imatinib capsules, anlitintablets, gifitinib tablets, apixaban tablets, acetate abitron tablets, liversaban tablets, etc., have passed / as if passingZhejiang Huahai, the first species to pass the consistency evaluation is chloratatan potassium tablets (2017/12), the first declared varieties are ebetan hydrochlorpyrifos tablets (2017/8);3Hengrui, Howson, Stone Pharmaceuticals, Colum steadily ahead of hengrui, Howson, Stone Pharmaceuticals, Colum, can be considered as the domestic drug research and development strength of the first echelon of pharmaceutical enterprises, imitation and innovation capabilities are ahead From the number of declared varieties statistics, in turn, Collum (26 varieties), Hengrui (21 varieties), stone medicine (20 varieties), and Howson, and from the number of varieties statistics, for The Collen (9 varieties), stone medicine (9 varieties), Howson (8 varieties), Hengrui (7 varieties); Hengrui/Howson/Stone Medicine/Koren, for the first time by consistency evaluation of varieties in turn see the figure below 4 Xinlitai, pharmaceutical friends, Beijing New performance bright the current, consistency through the varieties TOP10 of the last 3 for Shenzhen Xinlitai (7 varieties through), Chongqing Pharmaceutical Friends (7 varieties through), Zhejiang Jingxin (6 varieties through) Shenzhen Xinlitai for the first time through the varieties as the pillar products of hydrogen sulfate chloropiogre tablets, Xinlitai is precisely because the variety is well-known in the country, and the recent policy of 4 plus 7, but also triggered the future direction of the species uncertainty After the first variety passed, the calcinor tablets, the chlorpyrifos, the celiac benapri tablets, the left ethyl statin sliver, the pivastatin calcium tablets, the omesatan esters were all evaluated through/asseen Chongqing pharmaceutical friends, the first through the consistency evaluation of the varieties of afa osteomelized alcohol tablets, after the company's hydrochloric acid klinicin capsules, benzoic acid chlorpyrifos tablets, potassium chloride particles, pyridocca tablets, Entikavir tablets, hydrochloric acid wenrafasin tablets, all through / as if through the evaluation Zhejiang Jingxin, the first variety to pass the consistency evaluation of the varieties of Ruishuvastatin tablets, which is also a large variety; 5 The author of the small , the domestic current quality evaluation of generic drugs has been fruitful, the quality of generic drugs has been unquestionable, although the enterprise paid a lot, but indeed the road is necessary TOP10 enterprises to a certain extent on behalf of the domestic level of drug research and development, but also can see that some people often proud of the national size group enterprises, not on the list, the future market distribution will also be "technology and capital" to guide together and the status of generic drugs in the domestic issue, in fact, whether it is consistency evaluation, or "4 plus 7", or the recent discussion of whether the generic drug business is cut, to a certain extent to prove the importance of the quality of generic drugs, are in the cost attributes of generic drugs, are to a certain extent to guide the enterprise generic drugs should do!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.